Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 68.20
+0.40 (0.59%)
At close: Feb 12, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 758.11 million as of February 13, 2026.
Market Cap
758.11M
Enterprise Value
835.11M
Revenue
826.43M
Ranking
n/a
PE Ratio
6.94
Stock Price
68.20
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has decreased from 922.07M to 758.11M, a decrease of -17.78%. That is a compound annual growth rate of -23.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 758.11M | -22.37% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 966.18M |
| Source Natural Foods and Herbal Supplements | 875.42M |
| Zenith Drugs | 824.00M |
| Phaarmasia | 818.96M |
| Makers Laboratories | 795.67M |
| Amwill Health Care | 750.54M |
| Shelter Pharma | 697.57M |
| Asston Pharmaceuticals | 696.36M |